Cargando…
An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors
A developing family of chemotherapeutics—derived from 5-(4-phenoxybutoxy)psoralen (PAP-1)—target mitochondrial potassium channel mtKv1.3 to selectively induce oxidative stress and death of diseased cells. The key to their effectiveness is the presence of a positively charged triphenylphosphonium gro...
Autores principales: | Parrasia, Sofia, Rossa, Andrea, Varanita, Tatiana, Checchetto, Vanessa, De Lorenzi, Riccardo, Zoratti, Mario, Paradisi, Cristina, Ruzza, Paolo, Mattarei, Andrea, Szabò, Ildikò, Biasutto, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914648/ https://www.ncbi.nlm.nih.gov/pubmed/33562146 http://dx.doi.org/10.3390/ph14020129 |
Ejemplares similares
-
DA7R: A 7-Letter Zip Code to Target PDAC
por: Parrasia, Sofia, et al.
Publicado: (2023) -
Peptides
as Pharmacological Carriers to the Brain:
Promises, Shortcomings and Challenges
por: Parrasia, Sofia, et al.
Publicado: (2022) -
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo
por: Bachmann, Magdalena, et al.
Publicado: (2022) -
Novel Mitochondria-Targeted Furocoumarin Derivatives as Possible Anti-Cancer Agents
por: Mattarei, Andrea, et al.
Publicado: (2018) -
N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of Resveratrol
por: Mattarei, Andrea, et al.
Publicado: (2015)